CLINICAL_TRIALS
trial_result
· 2022-12-14
Clinical Trial Update: Treatment of Negative Symptoms and Schizophrenia [Phase 1, Phase 2]
Summary
A completed Phase 1/2 clinical trial investigating treatment for negative symptoms in schizophrenia conducted by University Hospital, Montpellier.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Montpellier | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED